Skip to content
Visit specialist site
Non-clinical specialist

Leonard Guarente, PhD

Co-Founder and Chief Scientist, Elysium Health · Elysium HealthSirtuin biology, NAD+ and aging, calorie restriction genetics, brain aging

MIT aging biologist and Elysium Chief Scientist known for foundational sirtuin and NAD+ research

View the practiceSource profileCredentials checked
Portrait of Leonard Guarente, PhD

At a glance

Years in practice
44
Languages
English

Practice

About

Leonard Guarente, PhD is Elysium Health's Co-Founder and Chief Scientist and the Novartis Professor of Biology at MIT, where he directs the Paul F. Glenn Center for Biology of Aging Research. His lab is central to sirtuin and NAD+ aging biology, including work identifying SIR2 as a longevity regulator and showing that sirtuins are NAD+-dependent enzymes. He co-founded Elysium in 2014 with Eric Marcotulli and Dan Alminana, giving the company a direct link to MIT aging-biology research.

Approach

Signature approach

Guarente's role is scientific foundation. Basis connects to his lab's NAD+/sirtuin body of work, while Index follows Elysium's broader pattern of taking academic aging-biology methods into consumer products. His presence gives Elysium a direct line to MIT biology instead of a purely commercial supplement or testing posture.

What sets them apart

  • Sirtuin/NAD+ lineage. Guarente's work helped define the field that made NAD+ biology central to consumer longevity.
  • MIT Glenn Center role. He directs a major academic aging-biology center while serving as Elysium's Chief Scientist.
  • Scientific family tree. David Sinclair, Brian K. Kennedy, and Matt Kaeberlein trained in his lab.
  • Publication scale. Semantic Scholar listed roughly 332 publications, h-index 137, and about 85K citations at capture.

Focus

Specialties

Sirtuins and NAD+ in agingSirtuin biology (research)

Training

Education

  • PhD
    Harvard University (1978)
  • SB, Biology
    Massachusetts Institute of Technology (1974)
Years in longevity
34

Published work

Elsewhere

Media and talks

Collaboration

  • David Sinclair, PhD
    Postdoc in Guarente lab (1993); now Harvard Medical School aging biologist
  • Brian K. Kennedy, PhD
    Doctoral student in Guarente lab; aging biologist (NUS, formerly Buck Institute)
  • Matt Kaeberlein, PhD
    Doctoral student in Guarente lab; aging biologist (formerly UW; Optispan)
  • Cynthia Kenyon, PhD
    Co-founder of Elixir Pharmaceuticals (1999) and parallel pioneer of aging genetics

Verification

Profile updated
Credentials checked
Affiliations verified

Primary sourcehttps://www.elysiumhealth.com/blogs/leadership-team/leonard-guarente-phd

Where a detail is missing, it means we have not verified it—not that the answer is no. Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.